RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000031.xml
Klin Monbl Augenheilkd 2021; 238(06): 674-678
DOI: 10.1055/a-1478-4277
DOI: 10.1055/a-1478-4277
Übersicht
Hornhautbanken: Perspektiven für die Zukunft
Artikel in mehreren Sprachen: English | deutsch
Zusammenfassung
Technologischer Fortschritt und gesellschaftliche Entwicklungen verändern die Medizin und machen auch vor Hornhautbanken nicht Halt. Neue infektiologische Aspekte, gesetzliche Vorgaben, Managementkonzepte, Globalisierung und Digitalisierung beeinflussen zusätzlich die zukünftigen Arbeitsinhalte dieser Einrichtungen. Das Ziel einer Bereitstellung von hochwertigem Material zur Versorgung von Patienten mit Hornhauterkrankungen bleibt bestehen. Welche Art von Material dies sein kann und unter welchen Rahmenbedingungen es entsteht soll der vorliegende Beitrag beleuchten.
Publikationsverlauf
Eingereicht: 26. Februar 2021
Angenommen: 17. März 2021
Artikel online veröffentlicht:
22. Juni 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References/Literatur
- 1 Cheema M, Aghazadeh H, Nazarali S. et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol 2020; 55: e125 DOI: 10.1016/j.jcjo.2020.03.003.
- 2 Collin J, Queen R, Zerti D. et al. Co-expression of SARS-CoV-2 entry genes in the superficial adult human conjunctival, limbal and corneal epithelium suggests an additional route of entry via the ocular surface. Ocul Surf 2021; 19: 190-200 DOI: 10.1016/j.jtos.2020.05.013.
- 3 Sadhu S, Agrawal R, Pyare R. et al. COVID-19: Limiting the Risks for Eye Care Professionals. Ocul Immunol Inflamm 2020; 28: 714-720 DOI: 10.1080/09273948.2020.1755442.
- 4 Desautels JD, Moshirfar M, Martheswaran T. et al. Risks Posed to Corneal Transplant Recipients by COVID-19-Affected Donors. Ophthalmol Ther 2020; 9: 371-379 DOI: 10.1007/s40123-020-00254-w.
- 5 Trigaux C, Salla S, Schroeter J. et al. SARS-CoV-2: Impact on, Risk Assessment and Countermeasures in German Eye Banks. Curr Eye Res 2020; DOI: 10.1080/02713683.2020.1828487.
- 6 Thuret G, Courrier E, Poinard S. et al. One threat, different answers: the impact of COVID-19 pandemic on cornea donation and donor selection across Europe. Br J Ophthalmol 2020; DOI: 10.1136/bjophthalmol-2020-317938.
- 7 Bayyoud T, Iftner T, Bartz-Schmidt KU. et al. First results of investigations of SARS-CoV-2 RNA in human corneal tissue. Ophthalmologe 2020; 117: 615-617 DOI: 10.1007/s00347-020-01151-0.
- 8 Miner JJ, Platt DJ, Ghaznavi CM. et al. HSV-1 and Zika Virus but Not SARS-CoV-2 Replicate in the Human Cornea and Are Restricted by Corneal Type III Interferon. Cell Rep 2020; 33: 108339 DOI: 10.1016/j.celrep.2020.108339.
- 9 Ballouz D, Mian SI. Eye banking in the coronavirus disease 2019 era. Curr Opin Ophthalmol 2020; 31: 389-395 DOI: 10.1097/ICU.0000000000000684.
- 10 Bundesärztekammer. Richtlinie zur Gewinnung von Spenderhornhäuten und zum Führen einer Augenhornhautbank, Erste Fortschreibung. Dtsch Arztebl 2018; 115: A1-A18 DOI: 10.3238/arztebl.2018.rl_augenhornhautbank_02.
- 11 Qu J-H, Peng R-M, Xiao G-G. et al. The incidence and influence of the donor corneas positive for herpesviridae DNA in keratoplasty. Graefes Arch Clin Exp Ophthalmol 2020; 258: 2767-2774 DOI: 10.1007/s00417-020-04984-2.
- 12 Holland EJ, Bennett SR, Brannian R. et al. The risk of cytomegalovirus transmission by penetrating keratoplasty. Am J Ophthalmol 1988; 105: 357-360 DOI: 10.1016/0002-9394(88)90297-8.
- 13 Córdoba A, Mejía LF, Mannis MJ. et al. Current Global Bioethical Dilemmas in Corneal Transplantation. Cornea 2020; 39: 529-533 DOI: 10.1097/ICO.0000000000002246.
- 14 Chaurasia S, Das S, Roy A. A review of long-term corneal preservation techniques: Relevance and renewed interests in the COVID-19 era. Indian J Ophthalmol 2020; 68: 1357-1363 DOI: 10.4103/ijo.IJO_1505_20.
- 15 Seitz B, Langenbucher A, Naumann GOH. [The penetrating keratoplasty. A 100-year success story]. Ophthalmologe 2005; 102: 1128-1136 1138–1139 DOI: 10.1007/s00347-005-1291-6.
- 16 Alio JL, Montesel A, El Sayyad F. et al. Corneal graft failure: an update. Br J Ophthalmol 2020; DOI: 10.1136/bjophthalmol-2020-316705.
- 17 Mahabadi N, Czyz CN, Tariq M, Havens SJ. Corneal Graft Rejection. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Accessed March 9 2021 at: http://www.ncbi.nlm.nih.gov/pubmed/30085585
- 18 Gain P, Jullienne R, He Z. et al. Global survey of corneal transplantation and eye banking. JAMA Ophthalmol 2016; 134: 167-173 DOI: 10.1001/jamaophthalmol.2015.4776.
- 19 Mahdavi SS, Abdekhodaie MJ, Mashayekhan S. et al. Bioengineering Approaches for Corneal Regenerative Medicine. Tissue Eng Regen Med 2020; 17: 567-593 DOI: 10.1007/s13770-020-00262-8.
- 20 Guérin LP, Le-Bel G, Desjardins P. et al. The Human Tissue-Engineered Cornea (hTEC): Recent Progress. Int J Mol Sci 2021; 22: 1291 DOI: 10.3390/ijms22031291.
- 21 Alió Del Barrio JL, Arnalich-Montiel F, De Miguel MP. et al. Corneal stroma regeneration: Preclinical studies. Exp Eye Res 2021; 202: 108314 DOI: 10.1016/j.exer.2020.108314.
- 22 McKay TB, Hutcheon AEK, Guo X. et al. Modeling the cornea in 3-dimensions: Current and future perspectives. Exp Eye Res 2020; 197: 108127 DOI: 10.1016/j.exer.2020.108127.
- 23 Brunette I, Roberts CJ, Vidal F. et al. Alternatives to eye bank native tissue for corneal stromal replacement. Prog Retin Eye Res 2017; 59: 97-130 DOI: 10.1016/j.preteyeres.2017.04.002.
- 24 Nonpassopon M, Niparugs M, Cortina MS. Boston type 1 keratoprosthesis: Updated perspectives. Clin Ophthalmol 2020; 14: 1189-1200 DOI: 10.2147/OPTH.S219270.
- 25 Sharifi R, Yang Y, Adibnia Y. et al. Finding an Optimal Corneal Xenograft Using Comparative Analysis of Corneal Matrix Proteins Across Species. Sci Rep 2019; 9: 1876 DOI: 10.1038/s41598-018-38342-4.
- 26 Riau AK, Liu YC, Yam GHF. et al. Stromal keratophakia: Corneal inlay implantation. Prog Retin Eye Res 2020; 75: 100780 DOI: 10.1016/j.preteyeres.2019.100780.
- 27 Flockerzi E, Maier P, Böhringer D. et al. Trends in Corneal Transplantation from 2001 to 2016 in Germany: A Report of the DOG-Section Cornea and its Keratoplasty Registry. Am J Ophthalmol 2018; 188: 91-98 DOI: 10.1016/j.ajo.2018.01.018.
- 28 Ong HS, Ang M, Mehta JS. Evolution of therapies for the corneal endothelium: past, present and future approaches. Br J Ophthalmol 2021; 105: 454-467 DOI: 10.1136/bjophthalmol-2020-316149.
- 29 Kinoshita S, Koizumi N, Ueno M. et al. Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy. N Engl J Med 2018; 378: 995-1003 DOI: 10.1056/NEJMoa1712770.
- 30 Fuest M, Yam GH, Peh GS. et al. Advances in corneal cell therapy. Regen Med 2016; 11: 601-615 DOI: 10.2217/rme-2016-0054.
- 31 Peh GSL, Ong HS, Adnan K. et al. Functional Evaluation of Two Corneal Endothelial Cell-Based Therapies: Tissue-Engineered Construct and Cell Injection. Sci Rep 2019; 9: 6087 DOI: 10.1038/s41598-019-42493-3.
- 32 Faye PA, Poumeaud F, Chazelas P. et al. Focus on cell therapy to treat corneal endothelial diseases. Exp Eye Res 2021; 204: 108462 DOI: 10.1016/j.exer.2021.108462.
- 33 Mehta JS, Kocaba V, Soh YQ. The future of keratoplasty: cell-based therapy, regenerative medicine, bioengineering keratoplasty, gene therapy. Curr Opin Ophthalmol 2019; 30: 286-291 DOI: 10.1097/ICU.0000000000000573.
- 34 Moloney G, Garcerant Congote D, Hirnschall N. et al. Descemet Stripping Only Supplemented With Topical Ripasudil for Fuchs Endothelial Dystrophy 12-Month Outcomes of the Sydney Eye Hospital Study. Cornea 2021; 40: 320-326 DOI: 10.1097/ICO.0000000000002437.
- 35 Menzel-Severing J, Schlötzer-Schrehardt U, Schrader S. et al. Transcorneal freezing and topical Rho-kinase inhibitor treatment in Fuchs Endothelial Corneal Dystrophy. Eye 2021; DOI: 10.1038/s41433-021-01520-2.
- 36 Ting DSJ, Foo VH, Yang LWY. et al. Artificial intelligence for anterior segment diseases: Emerging applications in ophthalmology. Br J Ophthalmol 2021; 105: 158-168 DOI: 10.1136/bjophthalmol-2019-315651.
- 37 Heinzelmann S, Daniel MC, Maier PC. et al. [Automated Cell Counting Using “Deep Learning” in Donor Corneas from Organ Culture Achieves High Precision and Accuracy]. Klin Monbl Augenheilkd 2019; 236: 1407-1412 DOI: 10.1055/a-1023-4339.
- 38 Canavesi C, Cogliati A, Hindman HB. Unbiased corneal tissue analysis using Gabor-domain optical coherence microscopy and machine learning for automatic segmentation of corneal endothelial cells. J Biomed Opt 2020; 25: 1-17 DOI: 10.1117/1.JBO.25.9.092902.
- 39 Hsu ST, Perry I, Botsay S. et al. Characterization of Corneal Donor Tissue Lesions by Anterior Segment Optical Coherence Tomography Compared With Eye Bank Technician Slit-Lamp Examination. Cornea 2018; 37: 1318-1323 DOI: 10.1097/ICO.0000000000001700.
- 40 Al Bourgol S, Ninotta S, Garcin T. et al. Detection of refractive photokeratectomy traces during eye banking: impossible with organ culture but possible with an active storage machine: case report. Cell Tissue Bank 2021; DOI: 10.1007/s10561-020-09895-4.
- 41 Alabi RO, Ansin A, Clover J. et al. Novel Use of Telemedicine for Corneal Tissue Evaluation in Eye Banking: Establishing a Standardized Approach for the Remote Evaluation of Donor Corneas for Transplantation. Cornea 2019; 38: 509-514 DOI: 10.1097/ICO.0000000000001848.
- 42 Birbal RS, Sikder S, Lie JT. et al. Donor Tissue Preparation for Descemet Membrane Endothelial Keratoplasty: An Updated Review. Cornea 2018; 37: 128-135 DOI: 10.1097/ICO.0000000000001368.
- 43 Moshirfar M, Thomson AC, Ronquillo Y. Corneal Endothelial Transplantation. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Accessed March 9, 2021 at: http://www.ncbi.nlm.nih.gov/pubmed/32965936
- 44 Menzel-Severing J, Walter P, Plum WJ. et al. Assessment of Corneal Endothelium during Continued Organ Culture of Pre-Stripped Human Donor Tissue for DMEK Surgery. Curr Eye Res 2018; 43: 1439-1444 DOI: 10.1080/02713683.2018.1501805.
- 45 Menzel-Severing J, Kruse FE, Tourtas T. Organ-cultured, prestripped donor tissue for DMEK surgery: clinical outcomes. Br J Ophthalmol 2017; 101: 1124-1127 DOI: 10.1136/bjophthalmol-2016-309550.
- 46 Safi T, Seitz B, Berg K. et al. Reproducibility of Non-Invasive Endothelial Cell Loss Assessment of the Pre-Stripped DMEK Roll After Preparation and Storage. Am J Ophthalmol 2021; 221: 17-26 DOI: 10.1016/j.ajo.2020.08.001.
- 47 Lam FC, Baydoun L, Dirisamer M. et al. Hemi-Descemet membrane endothelial keratoplasty transplantation: a potential method for increasing the pool of endothelial graft tissue. JAMA Ophthalmol 2014; 132: 1469-1473 DOI: 10.1001/jamaophthalmol.2014.3328.
- 48 Global Alliance of Eye Bank Associations Inc. (GAEBA). The Barcelona Principles. An Agreement on the Use of Human Donated Tissue for Ocular Transplantation, Research, and Future Technologies. Cornea 2018; 37: 1213-1217 DOI: 10.1097/ICO.0000000000001675.
- 49 Williams AM, Muir KW. Awareness and attitudes toward corneal donation: challenges and opportunities. Clin Ophthalmol 2018; 12: 1049-1059 DOI: 10.2147/OPTH.S142702.
- 50 Stiel S, Hermel M, Radbruch L. Cornea donation from patients deceased at a palliative care unit. Palliat Med 2011; 25: 183-184 DOI: 10.1177/0269216310385602.
- 51 Payne JW. New directions in eye banking. Trans Am Ophthalmol Soc 1980; 78: 983-1026
- 52 Moshirfar M, Goldberg JL, Brown TW. et al. A paradigm shift in eye banking: how new models are challenging the status quo. Clin Ophthalmol 2019; 13: 63-67 DOI: 10.2147/OPTH.S181534.
- 53 Moshirfar M. Response to “A paradigm shift in eye banking: how new models are challenging the status quo by Moshirfar et al”. Clin Ophthalmol 2019; 13: 597-598 DOI: 10.2147/OPTH.S210768.
- 54 Mannis MJ, Sugar J. Is This the Future of Eye Banking?. Cornea 2018; 37: 811-812 DOI: 10.1097/ICO.0000000000001616.